NeuroOne Medical Technologies Corp. (NMTC)
1.62
-0.04
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
NeuroOne Medical Technologies Debt to Equity Ratio : 0.0465 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0465 |
| March 31, 2026 | 0.0408 |
| December 31, 2025 | 0.0371 |
| September 30, 2025 | 0.0377 |
| June 30, 2025 | 0.0362 |
| March 31, 2025 | 0.2766 |
| December 31, 2024 | 0.1163 |
| September 30, 2024 | 0.3165 |
| June 30, 2024 | 0.0963 |
| March 31, 2024 | 0.0316 |
| December 31, 2023 | 0.0348 |
| September 30, 2023 | 0.0295 |
| June 30, 2023 | 0.0547 |
| March 31, 2023 | 0.0441 |
| December 31, 2022 | 0.0333 |
| September 30, 2022 | 0.0211 |
| June 30, 2022 | 0.0218 |
| March 31, 2022 | 0.0199 |
| December 31, 2021 | 0.0181 |
| September 30, 2021 | 0.0482 |
| June 30, 2021 | 0.0304 |
| March 31, 2021 | 0.0338 |
| December 31, 2020 | 0.2711 |
| September 30, 2020 | 0.6789 |
| June 30, 2020 | -1.817 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9852 |
| December 31, 2019 | -1.187 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.5151 |
| December 31, 2018 | -0.4171 |
| September 30, 2018 | -0.3814 |
| June 30, 2018 | -0.4752 |
| March 31, 2018 | -0.4495 |
| December 31, 2017 | -0.4807 |
| September 30, 2017 | -0.5967 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -1.034 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.2078 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.1455 |
| June 30, 2015 | -0.0963 |
| March 31, 2015 | -0.9143 |
| December 31, 2014 | -0.6384 |
| September 30, 2014 | -0.6745 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.186M |
| Total Liabilities (Quarterly) | 2.419M |
| Shareholders Equity (Quarterly) | 3.768M |
| Current Ratio | 2.820 |
| Net Debt Paydown Yield | 0.10% |